EZH2 and influenza: We investigated the role of EZH2 in pulmonary mucosal inflammation, and for this used inflammatory challenge models targeting the lung, including nebulized lipopolysaccharide, (LPS), as well as two pulmonary infectious disease models (influenza A and pneumococcus).